Skip to content
ClinicCompass
Tirzepatide (Zepbound / Mounjaro)
Medical Weight Loss

Tirzepatide (Zepbound / Mounjaro)

Weekly dual-action (GLP-1 + GIP) injection averaging ~20% body weight loss in trials, the strongest results of any weight-loss medication, and the winner of the first head-to-head trial against semaglutide.

Also called: Zepbound, Mounjaro, compounded tirzepatide, GLP-1, GIP, tirzepatide injections, tirzepatide weight loss

Medically reviewed by dermatologist Dr. Victoria Taraska, MD, FAAD, FRCPC

Cite this page

Typical cost

$300 to $1,100

per month

Sessions

Weekly self-injection; dose escalated over 20+ weeks, then ongoing

typical course

Downtime

None. Nausea and GI side effects are common during dose increases

Estimate your Tirzepatide (Zepbound / Mounjaro) cost by city →

Find a clinic

Find a Tirzepatide (Zepbound / Mounjaro) clinic near you

See the clinics in your city that offer it, compare reviews, and request a free consultation.

Your location is used once to pick the nearest city and is never stored.

Tirzepatide is the second act of the GLP-1 revolution, and by the numbers, the stronger one. Sold as Zepbound (FDA-approved for weight loss) and Mounjaro (approved for type 2 diabetes), it works on two gut-hormone pathways at once: GLP-1, like semaglutide, plus GIP, a second hormone involved in appetite and fat metabolism.

Why the dual mechanism matters

Semaglutide mimics one satiety hormone; tirzepatide mimics two. In practice that translated into the strongest clinical trial results the weight-loss field has ever produced: SURMOUNT-1 averaged ~20–22% body weight loss over 72 weeks at the top dose. And in 2025, the first true head-to-head trial (SURMOUNT-5) settled the debate on averages: tirzepatide patients lost roughly 20% of body weight versus roughly 14% on semaglutide.

Interestingly, many patients also report the nausea is a touch milder (possibly a GIP effect), though experiences vary.

What treatment looks like

Identical rhythm to semaglutide: labs and history first, then a weekly self-injection with the dose stepped up gradually over about five months. Expect 12–18+ months of treatment, with most of the loss in the first year, then a maintenance decision.

The cost picture shifted in patients’ favor when the manufacturer began selling Zepbound directly in single-dose vials at $349–$499/month cash, often undercutting what compounded versions used to cost, with none of the sourcing questions.

The honest trade-offs

Same fundamentals as every GLP-1: it works while you take it (the SURMOUNT-4 stop study showed about half the weight returning within a year of quitting), nausea is the toll at each dose increase, and rapid weight loss shows in your face. Patients finishing their weight-loss phase commonly turn to dermal fillers for facial volume, and CoolSculpting or Emsculpt NEO for the stubborn-spot cleanup that medication alone doesn’t do.

Weighing the two drugs? Our semaglutide vs. tirzepatide comparison covers results, price, side effects, and how to actually choose.

Why people choose Tirzepatide (Zepbound / Mounjaro)

  • Average ~20% body weight loss over 72 weeks in the SURMOUNT-1 trial, the strongest trial results in the category
  • Beat semaglutide head-to-head in the 2025 SURMOUNT-5 trial
  • Dual GLP-1 + GIP action; some patients report milder nausea than on semaglutide
  • Manufacturer's direct vial program has made cash pricing competitive
Are you a good candidate?

Adults with BMI 30+, or 27+ with a weight-related condition, wanting maximum medication-driven results and committed to ongoing treatment

By location

Find Tirzepatide (Zepbound / Mounjaro) near you

3,859 clinics across 446 cities list Tirzepatide (Zepbound / Mounjaro) on ClinicCompass. 2,458 of them (64%) say on their own websites that they offer financing or payment plans; ask about approval and interest before you book.

Austin Texas → Charlotte North Carolina → Nashville Tennessee → Tampa Florida → Calgary Alberta → Miami Florida → Phoenix Arizona → Denver Colorado → Atlanta Georgia → Dallas Texas → Toronto Ontario → Seattle Washington → Boston Massachusetts → Chicago Illinois → Houston Texas → Los Angeles California → New York New York → San Diego California → Portland Oregon → Minneapolis Minnesota → Las Vegas Nevada → Orlando Florida → San Francisco California → Philadelphia Pennsylvania → Detroit Michigan → Lubbock Texas → Scottsdale Arizona → Vancouver British Columbia → Fort Lauderdale Florida → San Antonio Texas → Montreal Quebec → Washington District of Columbia → West Palm Beach Florida → Newport Beach California → Beverly Hills California → Sacramento California → Salt Lake City Utah → San Jose California → Fort Worth Texas → Raleigh North Carolina → Baltimore Maryland → Columbus Ohio → Indianapolis Indiana → Kansas City Missouri → St. Louis Missouri → Jacksonville Florida → Cleveland Ohio → Pittsburgh Pennsylvania → Cincinnati Ohio → Milwaukee Wisconsin → Oklahoma City Oklahoma → Tucson Arizona → New Orleans Louisiana → Ottawa Ontario → Edmonton Alberta → Winnipeg Manitoba → Mississauga Ontario → Boise Idaho → Colorado Springs Colorado → Charleston South Carolina → Halifax Nova Scotia → Quebec City Quebec → Tulsa Oklahoma → Omaha Nebraska → Reno Nevada → Fresno California → Chattanooga Tennessee → Columbus Georgia → Maui Hawaii → Frisco Texas → Greenville South Carolina → Sioux Falls South Dakota → Long Island New York → Queens New York → Brooklyn New York → Hoboken New Jersey → Jersey City New Jersey → Coral Gables Florida → Surrey British Columbia → Langley British Columbia → Bellevue Washington → Palo Alto California → Rochester Minnesota → Buffalo New York → La Jolla California → Baton Rouge Louisiana → Gilbert Arizona → Naples Florida → Torrance California → Albuquerque New Mexico → Plano Texas → Boca Raton Florida → Rochester New York → El Paso Texas → Southlake Texas → Corpus Christi Texas → Naperville Illinois → Tacoma Washington → Temecula California → The Woodlands Texas → Madison Wisconsin → Henderson Nevada → Katy Texas → Pasadena California → Walnut Creek California → Wilmington North Carolina → Wilmington Delaware → Chandler Arizona → Tuscaloosa Alabama → Anchorage Alaska → Irvine California → Long Beach California → Myrtle Beach South Carolina → Schaumburg Illinois → Greensboro North Carolina → Richmond Virginia → Asheville North Carolina → Glendale California → Spokane Washington → Tallahassee Florida → Waco Texas → Winter Park Florida → Bellingham Washington → Franklin Tennessee → Huntsville Alabama → Gainesville Florida → Little Rock Arkansas → Carlsbad California → Portland Maine → Sarasota Florida → Wichita Kansas → Des Moines Iowa → Memphis Tennessee → Midland Texas → Burlington Ontario → Delray Beach Florida → Lafayette Louisiana → St. George Utah → Castle Rock Colorado → Charlottesville Virginia → McKinney Texas → Ocala Florida → Annapolis Maryland → Cherry Creek Colorado → Columbia South Carolina → Fargo North Dakota → Fayetteville North Carolina → Fort Myers Florida → Lancaster Pennsylvania → Redding California → Summerlin Nevada → Fayetteville Arkansas → Boulder Colorado → Buckhead Georgia → Palm Springs California → Worcester Massachusetts → Oak Brook Illinois → Cary North Carolina → Albany New York → Abbotsford British Columbia → Amarillo Texas → Kirkland Washington → Encinitas California → Bakersfield California → Burbank California → McAllen Texas → Savannah Georgia → Springfield Illinois → Springfield Massachusetts → Springfield Missouri → Springfield Ohio → Frederick Maryland → Oakville Ontario → Evansville Indiana → Yuma Arizona → Montgomery Alabama → Athens Georgia → Birmingham Alabama → Peoria Illinois → West Hollywood California → Marietta Georgia → Olympia Washington → Richmond British Columbia → Grand Rapids Michigan → Lakeland Florida → Mobile Alabama → Pensacola Florida → Stockton California → Tyler Texas → Virginia Beach Virginia → Richmond Hill Ontario → Yakima Washington → Pleasanton California → Burnaby British Columbia → Abilene Texas → Medford Oregon → Napa California → Erie Pennsylvania → Harrisburg Pennsylvania → Aventura Florida → Round Rock Texas → Alpharetta Georgia → Arlington Texas → Arlington Virginia → Cedar Rapids Iowa → Fort Collins Colorado → Monterey California → Palm Desert California → Rockford Illinois → Staten Island New York → Prescott Arizona → Carmel Indiana → Clarksville Tennessee → Roanoke Virginia → Gatineau Quebec → King of Prussia Pennsylvania → Destin Florida → Oshawa Ontario → Ann Arbor Michigan → Knoxville Tennessee → Manhattan New York → Modesto California → Riverside California → Sandy Springs Georgia → Santa Fe New Mexico → Santa Monica California → Santa Rosa California → Sugar Land Texas → Winston-Salem North Carolina → Santa Cruz California → Roseville California → Murfreesboro Tennessee → West Hartford Connecticut → Kalamazoo Michigan → Key West Florida → Kissimmee Florida → White Plains New York → Davenport Iowa → Manchester New Hampshire → Windsor Ontario → Bloomington Illinois → Cape Cod Massachusetts → Burlington Vermont → Honolulu Hawaii → Las Cruces New Mexico → San Mateo California → Santa Barbara California → Sioux City Iowa → Topeka Kansas → Visalia California → Norman Oklahoma → Spartanburg South Carolina → Cherry Hill New Jersey → Vaughan Ontario → Bend Oregon → Venice Florida → Jackson Mississippi → New Haven Connecticut → Jackson Tennessee → Bozeman Montana → Huntington Beach California → Louisville Kentucky → Oakland California → Providence Rhode Island → San Luis Obispo California → Shreveport Louisiana → Vero Beach Florida → Lehi Utah → Broken Arrow Oklahoma → Champaign Illinois → Roswell Georgia → Johns Creek Georgia → Lynchburg Virginia → Allentown Pennsylvania → Syracuse New York → Markham Ontario → Durham North Carolina → Bradenton Florida → Edina Minnesota → Eugene Oregon → Manhattan Beach California → Mesa Arizona → Port St. Lucie Florida → Provo Utah → Salem Oregon → Pearland Texas → Vancouver Washington → South Bend Indiana → Concord North Carolina → Appleton Wisconsin → Beaumont Texas → Flagstaff Arizona → Green Bay Wisconsin → Idaho Falls Idaho → Iowa City Iowa → Missoula Montana → Newport News Virginia → Redlands California → Denton Texas → Rockville Maryland → Fredericksburg Virginia → Lincoln Nebraska → Stamford Connecticut → Newton Massachusetts → Portsmouth New Hampshire → Bridgeport Connecticut → Daytona Beach Florida → Eau Claire Wisconsin → Greeley Colorado → Lexington Kentucky → Ogden Utah → Oxnard California → Toledo Ohio → Victoria British Columbia → Wichita Falls Texas → Killeen Texas → Bentonville Arkansas → Lee's Summit Missouri → Canton Ohio → Bonita Springs Florida → Hilton Head Island South Carolina → Princeton New Jersey → Pueblo Colorado → Rapid City South Dakota → Traverse City Michigan → Folsom California → Olathe Kansas → Scranton Pennsylvania → Cheyenne Wyoming → Kelowna British Columbia → Lansing Michigan → Edmond Oklahoma → Carson City Nevada → Hamilton Ontario → Laredo Texas → Lawrence Kansas → London Ontario → Melbourne Florida → Saskatoon Saskatchewan → York Pennsylvania → Coeur d'Alene Idaho → Kenosha Wisconsin → Augusta Georgia → Barrie Ontario → Reading Pennsylvania → St. Catharines Ontario → Owensboro Kentucky → Morristown New Jersey → Hartford Connecticut → Kitchener-Waterloo Ontario → Moncton New Brunswick → Charleston West Virginia → Rochester Michigan → Miami Beach Florida → Gainesville Georgia → Columbia Maryland → Woodbury Minnesota → Alexandria Virginia → Clearwater Florida → Maple Grove Minnesota → North Vancouver British Columbia → Rockwall Texas → Flower Mound Texas → Birmingham Michigan → Overland Park Kansas → Brentwood Tennessee → Georgetown Kentucky → Georgetown Texas → New Braunfels Texas → Longmont Colorado → Santa Clarita California → Brandon Florida → Ajax Ontario → Jupiter Florida → Hinsdale Illinois → Westlake Village California → Paramus New Jersey → Milton Ontario → Doral Florida → Fairfax Virginia → Summerville South Carolina → Wesley Chapel Florida → Orland Park Illinois → Brookfield Wisconsin → Aurora Ontario → Dublin Ohio → Westlake Ohio → Cambridge Ontario → Peachtree City Georgia → Cedar Park Texas → Garden City New York → Kailua Hawaii → Berkeley California → Twin Falls Idaho → Lake Oswego Oregon → Issaquah Washington → Whitby Ontario → Pickering Ontario → The Bronx New York → Rio Rancho New Mexico → Jackson Wyoming → St. Cloud Minnesota → Pocatello Idaho → Thousand Oaks California → Los Gatos California → Puyallup Washington → Sudbury Ontario → Dartmouth Nova Scotia → Red Bank New Jersey → The Villages Florida → Highlands Ranch Colorado → Framingham Massachusetts → Ridgewood New Jersey → Largo Florida → Danville California → Mill Valley California → Mandeville Louisiana → Quincy Massachusetts → Poughkeepsie New York → Stuart Florida → Fishers Indiana → Hot Springs Arkansas → Elk Grove California → Redmond Washington → Newmarket Ontario → Upper East Side New York → Morgantown West Virginia → Nashua New Hampshire → Coquitlam British Columbia → Allen Texas → Fairfield Connecticut → Newark Delaware → Yorkville Ontario → Brickell Florida → Plymouth Massachusetts → Surprise Arizona → Beaverton Oregon → Cranston Rhode Island → Hendersonville Tennessee → Danbury Connecticut → Goodyear Arizona → Palm Harbor Florida → Edison New Jersey → Saratoga Springs New York → Toms River New Jersey → Yonkers New York →
Free newsletter

Our free newsletter, once a month

The Compass is the ClinicCompass newsletter: what's new in aesthetics, what things cost, new clinics listed in your city, and what to ask before you book. Med spa, plastic surgery and dermatology, without the sales pitch.

Once a month, unsubscribe anytime. We never share your email with clinics or anyone else. Privacy.

From the blog

Tirzepatide (Zepbound / Mounjaro), in more depth

More on Tirzepatide (Zepbound / Mounjaro)
Frequently asked

Tirzepatide (Zepbound / Mounjaro) questions, answered

What's the difference between Mounjaro and Zepbound?

Same drug (tirzepatide), different approvals. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is approved for weight loss and obstructive sleep apnea. Weight-loss patients paying cash usually end up with Zepbound, which the manufacturer also sells directly in lower-cost single-dose vials.

Is tirzepatide really stronger than semaglutide?

On trial averages, yes. SURMOUNT-1 showed ~20–22% average body weight loss at the top dose, and the head-to-head SURMOUNT-5 trial (2025) found tirzepatide patients lost meaningfully more than semaglutide patients (~20% vs ~14%). Averages aren't individuals (plenty of people do great on semaglutide), but if maximum medication effect is the goal, tirzepatide is the current benchmark.

How much does tirzepatide cost per month?

Zepbound lists around $1,100/month, but the manufacturer's direct-to-patient vial program cut cash prices to roughly $349–$499/month depending on dose. Clinic and med spa programs using pharmacy-prepared tirzepatide have typically charged $300–$600/month with supervision included. As with semaglutide, compounding rules tightened after the FDA shortage designation ended. Ask exactly what's being dispensed.

What are the side effects?

Very similar profile to semaglutide: nausea during dose escalation, constipation or diarrhea, fatigue, reflux. Some patients tolerate tirzepatide's dual mechanism a bit better; others notice no difference. The serious-but-rare list is the same (pancreatitis, gallbladder issues), and the same thyroid-cancer-history exclusions apply. Rapid weight loss also means facial volume loss ('Ozempic face' applies here too), which many patients address with fillers or Sculptra.

Will I keep the weight off if I stop?

The SURMOUNT-4 withdrawal study answered this directly: patients who stopped tirzepatide regained about half the lost weight within a year, while those who continued kept losing. Like all GLP-1s, it's a long-term commitment: plan the maintenance strategy up front.

Who should choose tirzepatide over semaglutide?

Consider tirzepatide if: you want the strongest average results, you tried semaglutide with underwhelming effect, or cash price via the manufacturer's vial program beats your semaglutide options. Consider semaglutide if: your insurance covers Wegovy, you want the longest safety track record, or your provider's semaglutide program is meaningfully cheaper. Both beat every weight-loss medication that came before them.

Sources

Where this information comes from

Clinical facts on this page are checked against these primary sources.

  1. 1.FDA Approves New Medication for Chronic Weight Management, U.S. Food and Drug AdministrationZepbound (tirzepatide) is FDA-approved for chronic weight management, approved November 8, 2023, based on trial results showing substantial weight loss versus placebo.
  2. 2.ZEPBOUND- tirzepatide injection, solution - DailyMed, U.S. Food and Drug AdministrationZepbound's approved indications for chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity, the 15 mg maximum weekly dose, the boxed warning on thyroid C-cell tumors, the contraindication for personal or family history of medullary thyroid carcinoma or MEN 2, common side effects including nausea, diarrhea, vomiting, and constipation, and the SURMOUNT-1 trial result of 20.9% weight loss at the 15 mg dose versus 3.1% with placebo.
  3. 3.MOUNJARO- tirzepatide injection, solution - DailyMed, U.S. Food and Drug AdministrationMounjaro (tirzepatide) is FDA-approved for type 2 diabetes, and carries the same boxed warning on thyroid C-cell tumors, the same thyroid-history contraindications, and the same 15 mg maximum weekly dose as Zepbound.
  4. 4.Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial, JAMA (National Library of Medicine)The SURMOUNT-4 withdrawal trial found that patients switched from tirzepatide to placebo regained about half of the weight they had lost (from 20.9% loss at week 36 to a net 9.9% loss at week 88), while patients who continued treatment kept losing weight.
  5. 5.Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial, European Heart Journal Open (National Library of Medicine)The head-to-head SURMOUNT-5 trial found tirzepatide produced significantly greater weight loss than semaglutide, 20.2% versus 13.7% at 72 weeks.
  6. 6.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, U.S. Food and Drug AdministrationThe FDA declared the tirzepatide shortage resolved on December 19, 2024, and subsequently tightened restrictions on compounded tirzepatide.

Link to this page

Free to quote with a link back.

https://thecliniccompass.com/treatments/tirzepatide/